Ahmed Eldib, MD
Adult Reconstructive Orthopaedic Surgery · Morris, ILNPI 1144683624
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Stryker at 33.8% of the total. Reporting peaked in 2024 at $5,305 and has fallen 61.5% since, to $2,044 in 2025.
Across 92 payments — averaging $152.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Zimmer Biomet$4K
- W. L. Gore & Associates, Inc.$2K
- Medacta USA, Inc.$1K
- Medical Device Business Services, Inc.$964
- Encore Medical, LP$321
- plus $839 from 7 others
What the payments were for
- Consulting fees$1,54511%
- Speaking & faculty fees$1,64012%
- Travel & lodging$4,57833%
- Food & beverage$6,23945%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 32 | $4,729 |
| Zimmer Biomet | 32 | $4,309 |
| W. L. Gore & Associates, Inc. | 2 | $1,640 |
| Medacta USA, Inc. | 7 | $1,200 |
| Medical Device Business Services, Inc. | 8 | $964 |
| Encore Medical, LP | 3 | $321 |
| Johnson & Johnson | 2 | $223 |
| Linkbio Corp | 1 | $179 |
| Integra Lifesciences Corporation | 1 | $172 |
| Sanofi | 1 | $154 |
| AstraZeneca | 1 | $70 |
| Heron Therapeutics, Inc. | 1 | $26 |
| Next Science LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,001 in reported general payments places this provider in the 55th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.
See all adult reconstructive orthopaedic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 38 | $807 |
| Omeprazole | 76 | $395 |
| Cefadroxil | 43 | $364 |
| Celecoxib | 28 | $352 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $246 |
| Meloxicam | 53 | $134 |
| Tramadol Hcl | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Morris
- Wayne PaproskyWinfield$10.9M
- Scott SporerWinfield$5.3M
- Denis NamChicago$3.2M
- Craig della ValleChicago$2.4M
- Hany BedairChicago$1.1M
- Linda SuleimanChicago$898K
- Tad GerlingerChicago$642K
- Henry FinnChicago$523K
- Vasili KarasChicago$264K
- Brett LevineChicago$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.